Prevalence and clinical correlates of familial hypercholesterolemia founder mutations in the general population
Authors:
- 1 January 2015
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 238 (1) , 64-69
Abstract
No abstract availableKeywords
Funding Information
- Finnish Cultural Foundation
- Finnish Foundation for Cardiovascular Research
- Sigrid Juselius Foundation
- Research Council of Finland (129494, 139635)
This publication has 23 references indexed in Scilit:
- Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: A study of a cohort of 14,000 mutation carriersAtherosclerosis, 2014
- Integrated guidance on the care of familial hypercholesterolaemia from the International FH FoundationInternational Journal of Cardiology, 2014
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis SocietyEuropean Heart Journal, 2013
- Diagnosis and treatment of familial hypercholesterolaemiaEuropean Heart Journal, 2013
- Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering MedicationThe Journal of Clinical Endocrinology & Metabolism, 2012
- Description of a Large Family with Autosomal Dominant Hypercholesterolemia Associated with theAPOEp.Leu167del MutationHuman Mutation, 2012
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaNature Genetics, 2003
- Autosomal Recessive Hypercholesterolemia Caused by Mutations in a Putative LDL Receptor Adaptor ProteinScience, 2001
- Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding.Proceedings of the National Academy of Sciences, 1987
- A Receptor-Mediated Pathway for Cholesterol HomeostasisScience, 1986